Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Karen Eddy"'
Publikováno v:
Journal of Foot and Ankle Research, Vol 7, Iss 1, Pp n/a-n/a (2014)
Abstract Background There has been limited literature indicating that podiatrists' health may be at risk from exposure to human nail dust. Previous studies carried out in the UK have shown that large amounts of dust become airborne during the human n
Externí odkaz:
https://doaj.org/article/d733b615fa5c42b3afe75e29eb1ab51a
Supplementary Figures 1-2 from MicroRNA Responses to Cellular Stress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e10b634100d22c24917fbf039df3792
https://doi.org/10.1158/0008-5472.22366433
https://doi.org/10.1158/0008-5472.22366433
Recent work has begun to explore the instrumental role that small noncoding RNA species, particularly microRNAs (miRNA), have both in classifying human tumors and in directing embryonic development. These studies suggest that developmental programs i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41445d3bf2742325828c80e36691a4ac
https://doi.org/10.1158/0008-5472.c.6495140.v1
https://doi.org/10.1158/0008-5472.c.6495140.v1
Autor:
Jason Heth, Todd C. Hollon, Akshay V. Save, Balaji Pandian, Jeffrey N. Bruce, Peter Canoll, Sudharsan Srinivasan, Tamara Marie, Honglak Lee, Arjun R. Adapa, Kyle S. Conway, Wajd N. Al-Holou, Christian W. Freudiger, Esteban Urias, Karen Eddy, Oren Sagher, Zia Farooq, Daniel A. Orringer, Siri S. Khalsa, Neil K. Jairath, Sandra Camelo-Piragua
Publikováno v:
Neuro-Oncology. 23:144-155
Background Detection of glioma recurrence remains a challenge in modern neuro-oncology. Noninvasive radiographic imaging is unable to definitively differentiate true recurrence versus pseudoprogression. Even in biopsied tissue, it can be challenging
Autor:
Karen Eddy, Maria B. Garcia-Fabiani, Ruthvik Avvari, Ayman Taher, Brandon L. McClellan, Dolores Hambardzumyan, Maria Ventosa, Joshua D. Welch, Sofia D. Merajver, Syed M Faisal, Wajd N. Al-Holou, Maria G. Castro, Santiago Haase, Jason Heth, Chao Gao, Parag G. Patil, Felipe J Nunez, Rohit Thalla, Mahmoud S. Alghamri, Margaret S. Hartlage, Li Zhang, Gabriel Núñez, Shawn L. Hervey-Jumper, Pedro R. Lowenstein, Neha Kamran, Peter J. Ulintz, Jialin Liu, Daniel A. Orringer, Stephen Carney
Publikováno v:
Science Advances
Description
Mutant IDH1 gliomas are infiltrated by nonsuppressive immature myeloid cells, resulting in enhanced response to immunotherapy.
Mutant isocitrate-dehydrogenase 1 (mIDH1) synthesizes the oncometabolite 2-hydroxyglutarate (2HG), wh
Mutant IDH1 gliomas are infiltrated by nonsuppressive immature myeloid cells, resulting in enhanced response to immunotherapy.
Mutant isocitrate-dehydrogenase 1 (mIDH1) synthesizes the oncometabolite 2-hydroxyglutarate (2HG), wh
Autor:
Santiago Haase, Karen Eddy, Felipe J Nunez, Chao Gao, Ruthvik Avvari, Parag G. Patil, Maria G. Castro, Pedro R. Lowenstein, Syed M Faisal, Peter J. Ulintz, Dolores Hambardzumyan, Jason Heth, Gabriel Núñez, Stephen Carney, Shawn L. Hervey-Jumper, Neha Kamran, Joshua D. Welch, Jialin Liu, Daniel A. Orringer, Sophia Merajver, Rohit Thalla, Mahmoud S. Alghamri, Li Zhang, Maria B. Garcia-Fabiani, Maria Ventosa, Ayman Taher, Wajd N. Al-Holou
Mutation in isocitrate dehydrogenase (mIDH) is a gain of function mutation resulting in the production of the oncometabolite, R-2-hydroxyglutarate, that inhibits DNA and histone demethylases. The resultant hypermethylation phenotype reprograms the gl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bae9d17a8dc7914271073b3688dc83a
https://doi.org/10.1101/2020.07.22.215954
https://doi.org/10.1101/2020.07.22.215954
Autor:
Patil Pg, Karen Eddy, Jason Heth, Gao C, Gabriel Núñez, Welch J, Shawn L. Hervey-Jumper, Stephen Carney, Rohit Thalla, Mahmoud S. Alghamri, Li Zhang, Daniel A. Orringer, Neha Kamran, Ruthvik Avvari, Felipe J Nunez, Maria B. Garcia-Fabiani, Liu J, Ulintz Pj, Maria Ventosa, Merajver S, Pedro R. Lowenstein, Syed M Faisal, Santiago Haase, Dolores Hambardzumyan, Ayman Taher, Wajd N. Al-Holou, Maria G. Castro
Publikováno v:
Neuro Oncol
Mutation in isocitrate dehydrogenase (mIDH) is the main genetic lesion that defines clinical glioma subtypes and prognosis. This gain of function mutation is associated with the production of the oncometabolite, R-2-hydroxyglutarate, that inhibits α
Genomic hypomethylation is a hallmark of essentially all cancers, but the degree of this hypomethylation differs among individual tumors. Little work has explored what leads to these differences and or asked whether they are clinically meaningful. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63c59540256d8b2d6caceab0591a463b
https://europepmc.org/articles/PMC2633874/
https://europepmc.org/articles/PMC2633874/
Autor:
Karl T. Kelsey, Michael D. McClean, Debra Ting Hsiung, Karen Eddy, E. Andres Houseman, C. Sloane Furniss, Carmen J. Marsit
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 16(1)
Background: Head and neck squamous cell carcinoma (HNSCC) is commonly associated with tobacco and alcohol exposures, although dietary factors, particularly folate, and human papillomavirus, are also risk factors. Epigenetic alterations are increasing
Publikováno v:
Cancer research. 66(22)
Recent work has begun to explore the instrumental role that small noncoding RNA species, particularly microRNAs (miRNA), have both in classifying human tumors and in directing embryonic development. These studies suggest that developmental programs i